Zapata Computing Holdings ( ($ZPTA) ) just unveiled an update. On October 22, 2025, Zapata Quantum, Inc. entered into a Forbearance Agreement with ...
New patents granted for three technologies in five jurisdictions and four additional patent applications filed to date in 2025 Extends patent portfolio with new applications for quantum software ...
Zapata, the company behind Franky Zapata's English Channel jetpack crossing, will launch its AirScooter, a personal vertical takeoff and landing (VTOL) aircraft, in Las Vegas in early 2026. As an FAA ...
Quantum computing may be the next technology megatrend. Every few decades, a new technology megatrend comes around with the potential to transform the way people live and work. Most recently, these ...
Quantum computing promises to disrupt entire industries because it leverages the rules of quantum physics to perform calculations in fundamentally new ways. Unlike traditional computers that process ...
IonQ uses a trapped ion technique that provides superior accuracy. Rigetti Computing's superconducting process yields faster processing speeds. IonQ and Rigetti are taking two different approaches to ...
Shares in America’s “Quantum Four” quantum computing companies surged again yesterday. D-Wave, IonQ, Quantum Computing, and Rigetti all saw their stock prices jump by double-digit percentages. But why ...
Shares of Rigetti Computing Inc (NASDAQ:RGTI) are in the spotlight Tuesday after an equity research firm adjusted its price target on the quantum computing company. What To Know: Rigetti Computing ...
A JPMorgan Chase announcement caused many stocks in the sector to surge. We're still years away from widespread commercially available quantum computing. 10 stocks we like better than IonQ › Quantum ...
Rigetti Computing Inc (NASDAQ:RGTI) shares are trading lower Tuesday morning, a day after the quantum computing firm surged to a new all-time high. Here’s what investors need to know. What To Know: ...
BioNTech SE (BNTX) reports increased revenues and strategic advancements despite a net loss, as it focuses on oncology and AI-driven therapies.